Skip to main content

Table 5 Stratified analyses of association between the two SNPs and lung cancer risk by smoking exposure

From: Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer

SNP

Genotype

Smoking exposure

Controls (%)

Cases (%)

ORª (95% CI)

P value

Rs4848320

CC

Ever

88 (74.6)

58 (60.4)

1.00 (ref)

 

CT

 

29 (24.6)

32 (33.3)

1.695 (0.922–3.119)

0.090

TT

 

1 (0.8)

6 (6.3)

8.219 (0.957–70.618)

0.055

CT + TT vs CC

   

1.929 (1.070–3.479)

0.029

TT vs CT + CC

   

7.048 (0.827–60.092)

0.074

CC

Never

314 (66.1)

233 (68.9)

1.00 (ref)

 

CT

 

146 (30.7)

99 (29.3)

0.914 (0.671–1.245)

0.568

TT

 

15 (3.2)

6 (1.8)

0.563 (0.213–1.484)

0.245

CT + TT vs CC

   

0.882 (0.653–1.192)

0.415

TT vs CT + CC

   

0.578 (0.220–1.519)

0.266

Rs1110839

TT

Ever

50 (42.4)

30 (31.3)

1.00 (ref)

 

TG

 

62 (52.5)

53 (55.2)

1.376 (0.763–2.482)

0.288

GG

 

6 (5.1)

13 (13.5)

3.224 (1.089–9.544)

0.034

TG + GG vs TT

   

1.539 (0.867–2.731)

0.141

GG vs TG + TT

   

2.652 (0.954–7.371)

0.062

TT

Never

200 (42.1)

144 (42.6)

1.00 (ref)

 

TG

 

212 (44.6)

156 (46.2)

1.010 (0.748–1.364)

0.950

GG

 

63 (13.3)

38 (11.2)

0.847 (0.534–1.341)

0.478

TG + GG vs TT

   

0.973 (0.731–1.294)

0.849

GG vs TG + TT

   

0.842 (0.546–1.299)

0.437

  1. SNP single nucleotide polymorphism, OR odds ratio, CI confident interval
  2. ORa was adjusted by age and gender